Publications by authors named "M Drijkoningen"

Claim this Profile
Q
Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis.
Vanya Van Belle, Ben Van Calster, Olivier Brouckaert, Isabelle Vanden Bempt, Saskia Pintens, Maria Drijkoningen

J Clin Oncol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantity and quality of retrograde menstruation: a case control study.
Attila Bokor, Sophie Debrock, Maria Drijkoningen, Willy Goossens, Vilmos Fülöp

Reprod Biol Endocrinol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1.
S Pintens, P Neven, M Drijkoningen, V Van Belle, P Moerman

J Clin Pathol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belgian consensus guidelines for follow-up of women with cervical cytological abnormalities.
C A Cuvelier, J P M Bogers, C Bourgain, Ph Delvenne, M Drijkoningen

Acta Clin Belg· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing.
Isabelle Vanden Bempt, Peter Van Loo, Maria Drijkoningen, Patrick Neven, Ann Smeets

J Clin Oncol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis